Compare IDEXX Laboratories, Inc. (IDXX) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? IDEXX Laboratories, Inc. trades at $560 (market cap $44.48B), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.92. Which is the better fit depends on your goals.
| IDXX | SJNK | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Sector/Thematic |
52-Week High | $766.68 | $25.63 |
52-Week Low | $520.87 | $24.75 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
SJNK trades at $24.92 with no price change in the last 24 hours, showing technical bearish signals from moving averages while oscillators remain neutral. The ETF maintains consistent dividend payments with recent distributions of $0.14-$0.15 per share. Current technical analysis indicates bearish momentum with key support and resistance clustered around $25 levels.
The short-term high-yield bond ETF faces headwinds from potential yield normalization after benefiting from falling rates. Analyst sentiment appears cautious with recent bearish ratings citing exhausted tailwinds. Key risks include interest rate sensitivity and credit spread volatility in the junk bond market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →
